Keybank National Association OH boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 76,898 shares of the medical equipment provider’s stock after acquiring an additional 16,705 shares during the quarter. Keybank National Association OH owned 0.07% of Intuitive Surgical worth $36,828,000 as of its most recent filing with the SEC.
Other institutional investors also recently added to or reduced their stakes in the company. Financial Advantage Inc. purchased a new position in Intuitive Surgical in the 4th quarter valued at $36,000. Moody National Bank Trust Division purchased a new position in Intuitive Surgical in the 4th quarter valued at $38,000. Cornerstone Advisors Inc. lifted its holdings in Intuitive Surgical by 32.3% in the 3rd quarter. Cornerstone Advisors Inc. now owns 123 shares of the medical equipment provider’s stock valued at $71,000 after purchasing an additional 30 shares in the last quarter. Shine Investment Advisory Services Inc. purchased a new position in Intuitive Surgical in the 4th quarter valued at $75,000. Finally, Arrow Financial Corp purchased a new position in Intuitive Surgical in the 3rd quarter valued at $115,000. 84.75% of the stock is currently owned by hedge funds and other institutional investors.
In related news, VP Jamie Samath sold 227 shares of the firm’s stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $541.86, for a total transaction of $123,002.22. Following the completion of the sale, the vice president now directly owns 138 shares of the company’s stock, valued at approximately $74,776.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Salvatore Brogna sold 2,090 shares of the firm’s stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $541.88, for a total value of $1,132,529.20. Following the sale, the chief operating officer now directly owns 2,049 shares of the company’s stock, valued at $1,110,312.12. The disclosure for this sale can be found here. Insiders have sold a total of 70,386 shares of company stock valued at $37,436,871 over the last three months. Corporate insiders own 2.20% of the company’s stock.
ISRG has been the topic of a number of research reports. Citigroup decreased their price objective on Intuitive Surgical from $606.00 to $601.00 and set a “buy” rating on the stock in a report on Thursday, November 29th. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $615.00 price target on the stock in a report on Wednesday, December 5th. Stifel Nicolaus reduced their price target on Intuitive Surgical from $600.00 to $570.00 and set a “buy” rating on the stock in a report on Friday, January 25th. Cantor Fitzgerald reiterated a “buy” rating and set a $620.00 price target on shares of Intuitive Surgical in a report on Friday, January 25th. Finally, BidaskClub lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Wednesday, January 30th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $566.40.
Shares of NASDAQ:ISRG traded up $1.99 during midday trading on Friday, reaching $551.86. 564,727 shares of the company’s stock were exchanged, compared to its average volume of 796,956. The company has a market capitalization of $62.95 billion, a price-to-earnings ratio of 58.15, a PEG ratio of 4.16 and a beta of 1.12. Intuitive Surgical, Inc. has a fifty-two week low of $393.57 and a fifty-two week high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 24th. The medical equipment provider reported $2.96 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.07 by ($0.11). The business had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.05 billion. Intuitive Surgical had a return on equity of 18.11% and a net margin of 30.29%. The firm’s revenue for the quarter was up 17.3% compared to the same quarter last year. During the same period in the previous year, the business posted $2.54 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 10.07 EPS for the current year.
Intuitive Surgical Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Article: Rule of 72
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.